Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity

  • Planas-Serra, Laura|||0000-0002-2586-0897
  • Launay, Nathalie|||0000-0002-7498-217X
  • Goicoechea, Leire|||0000-0001-5024-1396
  • Heron, Bénédicte
  • Jou, Cristina|||0000-0002-2223-7880
  • Juliá-Palacios, Natalia
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Fourcade, Stéphane|||0000-0002-8031-5007
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • De La Torre, Carolina
  • Gelot, Antoniette
  • Marsal, Maria|||0000-0001-9678-8717
  • Loza-Alvarez, Pablo|||0000-0002-3129-1213
  • García-Cazorla, Àngels
  • Fatemi, Ali
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Portero-Otin, Manel
  • Area Gómez, Estela|||0000-0002-0962-1570
  • Pujol, Aurora|||0000-0002-9606-0600
Sphingolipids function as membrane constituents and signaling molecules, with crucial roles in human diseases, from neurodevelopmental disorders to cancer, best exemplified in the inborn errors of sphingolipid metabolism in lysosomes. The dihydroceramide desaturase Δ4-dihydroceramide desaturase 1 (DEGS1) acts in the last step of a sector of the sphingolipid pathway, de novo ceramide biosynthesis. Defects in DEGS1 cause the recently described hypomyelinating leukodystrophy-18 (HLD18) (OMIM #618404). Here, we reveal that DEGS1 is a mitochondria-associated endoplasmic reticulum membrane-resident (MAM-resident) enzyme, refining previous reports locating DEGS1 at the endoplasmic reticulum only. Using patient fibroblasts, multiomics, and enzymatic assays, we show that DEGS1 deficiency disrupts the main core functions of the MAM: (a) mitochondrial dynamics, with a hyperfused mitochondrial network associated with decreased activation of dynamin-related protein 1; (b) cholesterol metabolism, with impaired sterol O-acyltransferase activity and decreased cholesteryl esters; (c) phospholipid metabolism, with increased phosphatidic acid and phosphatidylserine and decreased phosphatidylethanolamine; and (d) biogenesis of lipid droplets, with increased size and numbers. Moreover, we detected increased mitochondrial superoxide species production in fibroblasts and mitochondrial respiration impairment in patient muscle biopsy tissues. Our findings shed light on the pathophysiology of HLD18 and broaden our understanding of the role of sphingolipid metabolism in MAM function.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy

  • Verdura, Edgard|||0000-0003-3856-2060
  • Rodríguez-Palmero, Agustí|||0000-0002-4141-5515
  • Vélez-Santamaria, Valentina
  • Planas-Serra, Laura|||0000-0002-2586-0897
  • de la Calle, Irene|||0000-0002-2227-1640
  • Raspall-Chaure, Miquel|||0000-0002-3132-3342
  • Roubertie, Agathe
  • Benkirane, Mehdi
  • Saettini, Francesco|||0000-0003-0767-3905
  • Pavinato, Lisa|||0000-0002-7630-8365
  • Mandrile, Giorgia
  • O'Leary, Melanie
  • O'Heir, Emily
  • Barredo, Estibaliz
  • Chacón, Almudena
  • Michaud, Vincent|||0000-0002-5788-392X
  • Goizet, Cyril
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Schlüter, Agatha|||0000-0001-6732-1528
  • Rouvet, Isabelle
  • Sala-Coromina, Júlia|||0000-0001-5116-6316
  • Fossati, Chiara
  • Iascone, Maria
  • Canonico, Francesco
  • Marcé-Grau, Anna|||0000-0001-5762-4023
  • de Souza, Precilla
  • Adams, David R.
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • Rehm, Heidi L.
  • Mefford, Heather C.|||0000-0001-7188-522X
  • González Gutiérrez-Solana, Luis|||0000-0003-2890-4565
  • Brusco, Alfredo|||0000-0002-8318-7231
  • Koenig, Michel
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Pujol, Aurora|||0000-0002-9606-0600
Phosphoinositides are lipids that play a critical role in processes such as cellular signalling, ion channel activity and membrane trafficking. When mutated, several genes that encode proteins that participate in the metabolism of these lipids give rise to neurological or developmental phenotypes. PI4KA is a phosphoinositide kinase that is highly expressed in the brain and is essential for life. Here we used whole exome or genome sequencing to identify 10 unrelated patients harbouring biallelic variants in PI4KA that caused a spectrum of conditions ranging from severe global neurodevelopmental delay with hypomyelination and developmental brain abnormalities to pure spastic paraplegia. Some patients presented immunological deficits or genito-urinary abnormalities. Functional analyses by western blotting and immunofluorescence showed decreased PI4KA levels in the patients' fibroblasts. Immunofluorescence and targeted lipidomics indicated that PI4KA activity was diminished in fibroblasts and peripheral blood mononuclear cells. In conclusion, we report a novel severe metabolic disorder caused by PI4KA malfunction, highlighting the importance of phosphoinositide signalling in human brain development and the myelin sheath. Verdura et al. report a novel rare brain metabolic disorder caused by recessive mutations in PI4KA, which encodes an enzyme with a pivotal role in phosphoinositide metabolism at the cell membrane. The description of this syndrome will simplify the identification of undiagnosed cases with similar clinical features.